Drug Pipeline
New drugs and how they are managed continue to be a major factor in pharmacy trend.
Four new drugs to treat migraines as they are happening are approaching approval from the U.S. Food and Drug... More
Feature
Insights provides context and perspective about key pharmacy trends and issues
Drug Pipeline
New drugs and how they are managed continue to be a major factor in pharmacy trend.
Biosimilars are a critical tool PBMs can use to help increase market competition and lower costs – we made changes to... More
Feature
Drug Pipeline
New drugs and how they are managed continue to be a major factor in pharmacy trend.
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage... More
Feature
Insights offers context and perspective about key pharmacy and health care topics.
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1-Q2 2018 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2017-Q1 2018 More
Specialty Report
Drug Pipeline
The market for migraine medications is ripe for growth due to a large patient population with an unmet clinical need. Four investigational medications known CGRP inhibitors will dominate... More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2017 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2017 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1-Q2 2017 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2016-Q1 2017 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2016 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2016 More
Specialty Report